(Q44695200)

English

The classical and alternative pathways of complement activation play distinct roles in spontaneous C3 fragment deposition and membrane attack complex (MAC) formation on human B lymphocytes

scientific article published in January 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

The classical and alternative pathways of complement activation play distinct roles in spontaneous C3 fragment deposition and membrane attack complex (MAC) formation on human B lymphocytes (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

based on heuristic

inferred from title

Claus H. Nielsen

2

object named as

Claus Henrik Nielsen

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

author name string

Robert Graham Quinton Leslie

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

111

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

86-90

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

CR2-mediated activation of the complement alternative pathway results in formation of membrane attack complexes on human B lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

The role of complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) in promoting C3 fragment deposition and membrane attack complex formation on normal peripheral human B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

The requirement of localized, CR2-mediated, alternative pathway activation of complement for covalent deposition of C3 fragments on normal B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

Structure of a C-type mannose-binding protein complexed with an oligosaccharide

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

Purification, characterization, and cDNA cloning of a novel growth factor from the conditioned medium of NIH-Sape-4, an embryonic cell line of Sarcophaga peregrina (flesh fly).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

A comparative study of normal B cells and the EBV-positive Burkitt's lymphoma cell line, Raji, as activators of the complement system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

Identification of distinct C3b and C4b recognition sites in the human C3b/C4b receptor (CR1, CD35) by deletion mutagenesis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

Activation of human CD4+ cells with CD3 and CD46 induces a T-regulatory cell 1 phenotype

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

B cells turn off virgin but not memory T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

The influence of complement receptor type 1 (CD35) and decay-accelerating factor (CD55) on complement receptor type 2- (CD21) mediated alternative pathway activation by B cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

A further link between innate and adaptive immunity: C3 deposition on antigen-presenting cells enhances the proliferation of antigen-specific T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2567.2004.01780.X

21 January 2018

Functionally active C1 on the surface of human peripheral lymphocytes: Its role in the complement-mediated inhibition of the Fc receptor of B lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/14678202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity

1 reference

https://pubmed.ncbi.nlm.nih.gov/14678202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibodies recognizing a neoantigen of poly(C9) detect the human terminal complement complex in tissue and plasma

1 reference

https://pubmed.ncbi.nlm.nih.gov/14678202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/14678202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CR2 is the primary acceptor site for C3 during alternative pathway activation of complement on human peripheral B lymphocytes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/14678202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel human serum lectin with collagen- and fibrinogen-like domains that functions as an opsonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/14678202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel mechanism of alternative pathway complement activation accounts for the deposition of C3 fragments on CR2-expressing homologous cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/14678202

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2567.2004.01780.X

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44695200&oldid=2067461293"